AcouSort AB (ACOU) - Total Liabilities

Latest as of September 2025: Skr3.21 Million SEK ≈ $345.34K USD

Based on the latest financial reports, AcouSort AB (ACOU) has total liabilities worth Skr3.21 Million SEK (≈ $345.34K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ACOU year-over-year net asset growth to track the company's year-over-year net asset growth rate.

AcouSort AB - Total Liabilities Trend (2013–2024)

This chart illustrates how AcouSort AB's total liabilities have evolved over time, based on quarterly financial data. See AcouSort AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

AcouSort AB Competitors by Total Liabilities

The table below lists competitors of AcouSort AB ranked by their total liabilities.

Company Country Total Liabilities
Kibo Energy PLC
JSE:KBO
South Africa ZAC3.83 Million
Bong AB (publ)
ST:BONG
Sweden Skr934.30 Million
Accuracy Shipping Limited
NSE:ACCURACY
India Rs1.83 Billion
Morgan Advanced Materials plc
LSE:MGAM
UK GBX668.20 Million
Muza S.A
WAR:MZA
Poland zł18.13 Million
Buru Energy Ltd
AU:BRU
Australia AU$14.49 Million
Sedania Innovator Bhd
KLSE:0178
Malaysia RM43.88 Million
Sanwil Holding SA
WAR:SNW
Poland zł13.72 Million

Liability Composition Analysis (2013–2024)

This chart breaks down AcouSort AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AcouSort AB stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AcouSort AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AcouSort AB (2013–2024)

The table below shows the annual total liabilities of AcouSort AB from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 Skr3.86 Million
≈ $415.51K
-62.80%
2023-12-31 Skr10.38 Million
≈ $1.12 Million
-53.96%
2022-12-31 Skr22.54 Million
≈ $2.43 Million
+537.14%
2021-12-31 Skr3.54 Million
≈ $380.75K
-1.15%
2020-12-31 Skr3.58 Million
≈ $385.16K
+69.38%
2019-12-31 Skr2.11 Million
≈ $227.39K
+13.60%
2018-12-31 Skr1.86 Million
≈ $200.17K
+74.81%
2017-12-31 Skr1.06 Million
≈ $114.50K
-48.94%
2016-12-31 Skr2.08 Million
≈ $224.27K
+1044.60%
2015-12-31 Skr182.07K
≈ $19.59K
-66.51%
2014-12-31 Skr543.60K
≈ $58.50K
-74.88%
2013-12-31 Skr2.16 Million
≈ $232.88K
--

About AcouSort AB

ST:ACOU Sweden Biotechnology
Market Cap
$7.81 Million
Skr72.59 Million SEK
Market Cap Rank
#27635 Global
#607 in Sweden
Share Price
Skr3.43
Change (1 day)
-2.83%
52-Week Range
Skr2.13 - Skr4.99
All Time High
Skr31.61
About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC … Read more